Related Experiment Video

Updated: May 3, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.2K

[Pro-apoptosis and selective anticancer activities of prostate apoptosis response protein 4: research progress and

Zengding Wu1, Guanlin Wang, Kuanren Zhang

  • 1Lab of Molecular Pharmacology, Kunming University of Science and Technology, Kunming 650500, China.

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|January 28, 2014
PubMed
Abstract

Insights

Prostate apoptosis response protein 4 (Par-4) and its core domain SAC selectively induce cancer cell apoptosis, offering potential as targeted anti-cancer drugs. Research explores their clinical application and challenges.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Drug Discovery

Context:

  • Prostate apoptosis response protein 4 (Par-4) is a pro-apoptotic factor identified in male hormone-dependent prostate cells.
  • Endogenous Par-4 sensitizes cancer cells to apoptosis, while exogenous Par-4 selectively induces apoptosis in cancer cells.
  • The apoptotic activity of Par-4 is dependent on the structure of its core domain, SAC.

Purpose:

  • To review the discovery, structure, function, and intracellular signaling pathways of Par-4.
  • To discuss the potential clinical applications of Par-4 and SAC as anti-cancer drugs.
  • To identify challenges in the research and clinical application of Par-4 and SAC.

Summary:

  • Par-4 and its SAC domain selectively induce apoptosis in cancer cells, sparing normal cells.
  • This selective action positions Par-4 and SAC as promising candidates for targeted cancer therapy.
  • The review covers Par-4's biology, signaling, and therapeutic prospects, alongside research and clinical hurdles.

Impact:

  • Highlights Par-4 and SAC as potential targeted anti-cancer therapeutics.
  • Provides a comprehensive overview of Par-4's role in cancer apoptosis.
  • Informs future research directions and clinical strategies for Par-4-based cancer treatments.

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

9.3K
Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

17.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
99
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K